The Role of Packaging Design In Drug Development - Pubrica
                     THE ROLE OF  
PACKAGING DESIGN IN  
DRUG DEVELOPMENT
An Academic presentation by
Dr. Nancy Agnes, Head, Technical Operations, Pubrica 
 Group: www.pubrica.com
Email: [email protected]
Today's Discussion
 
Outline Introduction
Packaging Is Key to Maintaining Drug 
Stability  Packaging Considerations for 
Generics
New Healthcare Markets Bring New 
Challenges  Conclusion
Introduction
Packaging is a significant segment in developing  
different drugs, as it can incredibly influence drug security  
and wellbeing.
P ackaging material is picked based on its viability and  
different attributes that empower it to save the quality,  
power, and health of the drug items.
Contd...
As the business advances, the packaging is getting more significant both to the  
fruitful promoting of items and to the health and security of patients.
As an outcome, there are more reasons than any time in recent memory to  
incorporate bundling contemplations from the get-go in the medication  
development measure.
Packaging Is Stability testing of drug items and similarity testing  
Key  to of packaging materials are fundamental pieces of  
R&D in the drug business.
Maintaining  
Drug Stability The security of medication in solid and fluid  
measurement structures relies upon the adequacy  
of the bundling materials to shield the medication  
from compound debasement and changes in  
essential qualities like appearance, hardness,  
friability, disintegration, deterioration, weight variety, 
 dampness content, and mechanical toughness.
This is exceptionally fundamental for the capacity of 
 items under speed-up conditions.

Packaging  
Consideration
s  for Generics
Generic companies frequently follow the innovator or  
reference bundling for their item.
However, the nonexclusive medication item plan  
group needs to consider the significance of bundling  
at a previous phase of improvement.
Contd...
Albeit the name of the medication item is something similar, there might
be  numerous distinctions in the item, for example,
Source of the API, and excipient.
Quantitative extents of active drug ingredients.
Drug producing process and parameters because of the presence of licenses  
and exclusivity.
New Healthcare 
 Markets Bring  
New Challenges Packaging in the healthcare industry faces
various  obstacles, including ever-
irnecqrueiaresminegntsre ignu ala ntourmyber of countries.
Packaging changes are being driven by complex  
molecules/formulas and biologics, which interfere with  
traditional packaging materials.
Contd...
With the growing demand for new packaging materials and the need to maintain  
product-package compatibility during the R&D stage to ensure the materials'  
protection, the task of the packaging technologist should not be overlooked during  
the product development process.
Industry developments are driving the use of cost-effective, creative packaging  
solutions today.
This is also another reason why it is important to consider packaging during the  
early stages of drug production to prevent any surprises during commercialization.
Contd...
To be effective, changes in hospital administration toward more self-administration  
processes necessitate consistent medical communication of product usages,  
packaging system simplification, and highly compliant packaging.
Although packaging is crucial for the marketing of any pharmaceutical product,  
pharmaceutical packaging is heavily regulated.
As a result, it is critical for pharma R&D packaging professionals to strike a  
balance between meeting safety, efficiency, and regulatory requirements while  
minimising costs during the early stages of production.
Conclusion
In recent years, there has been a larger focus on protecting  
drug transportation (cold chain, drop checks, etc.) and  
maintaining drug purity (track and trace, serialisation), both  
of which include packaging R&D.
Contact 
Us
UNITED KINGDOM
+44- 7424810299
INDIA
+91-9884350006
EMAIL
[email protected]